Intellia Therapeutics Inc

NTLANASDAQ · US

Holders

REDUCEDT+7
Dube Michael P
Intellia Therapeutics Inc · NASDAQ
−1,864 sh · $23.2K
Filed 6 Oct 2026SEC Form 4view source
REDUCEDStale
Leonard John M
Intellia Therapeutics Inc · NASDAQ
−2,785 sh · $36.2K
Filed 24 Aug 2026SEC Form 4view source
REDUCEDStale
Leonard John M
Intellia Therapeutics Inc · NASDAQ
−19,890 sh · $250.6K
Filed 24 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
ARK Investment Management
Intellia Therapeutics Inc · NASDAQ
16,875,684 sh · $285.5M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Intellia Therapeutics Inc · NASDAQ
4,705,901 sh · $60.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Intellia Therapeutics Inc · NASDAQ
14,509,247 sh · $186.0M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Intellia Therapeutics Inc · NASDAQ
14,207,324 sh · $127.7M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Intellia Therapeutics Inc · NASDAQ
11,919,178 sh · $205.8M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Intellia Therapeutics Inc · NASDAQ
13,017,876 sh · $122.1M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Intellia Therapeutics Inc · NASDAQ
9,597,607 sh · $214.8M
Filed 30 Jun 2024SEC 13Fview source